BIG
EOLS icon

Brooklyn Investment Group’s Evolus EOLS Stock Holding History

Brooklyn Investment Group’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,735
Closed -$411K – 1902
2025
Q4 		$411K Buy
+61,735
New +$418K 0.02% 810

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brooklyn Investment Group's EOLS Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Evolus (EOLS) in Q1 2026, closing a stake of 61,735 shares — an estimated $411K sold.

Brooklyn Investment Group first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $411K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 61,735 Evolus shares in Q1 2026, an estimated $411K.
  • Brooklyn Investment Group first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
  • Brooklyn Investment Group's Evolus position peaked at $411K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.